Global Med Technologies(R) to Report Third Quarter and Nine-Month Financial Results on Thursday, November 13, 2008
November 03 2008 - 9:00AM
PR Newswire (US)
Conference Call to Follow Release DENVER, Nov. 3
/PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global
Med" or the "Company") (OTC:GLOB) (BULLETIN BOARD: GLOB) , an
international e-Health, medical information technology company,
will report its third quarter and nine month financial results on
Thursday, November 13, 2008, before the market opens. The Company
will host a conference call at 9:00 a.m. EST on the same day.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)
Dr. Mick Ruxin, Chief Executive Officer, Tom Marcinek, President
and Chief Operating Officer, and Darren Craig, Vice President of
Finance, will discuss the third quarter and nine-month financial
results, as well as major company developments, and will be
available to answer questions. The one-hour conference call will be
held on November 13, 2008, at 9:00 a.m. EST. Interested parties are
welcome to call the telephone numbers listed below five minutes
prior to the start of the conference call. Callers within the U.S.
should call: 1-866-789-9224. Callers that are outside of the U.S.
should call: 1-706-679-9621. Callers should reference "Global Med
Third Quarter Financial Results" to the conference call operator.
The conference call ID number will be: 71180318. An automated
replay of the conference call will be available from November 13,
2008 at 11:30 a.m. EST until November 15, 2008 at 11:59 p.m. EST.
To access the replay, callers within the U.S. should call:
1-800-642-1687. Callers outside of the U.S. should call:
1-706-645-9291 and enter Global Med's access code of 71180318. The
replay of the conference call will be available from November 15,
2008 onward at Global Med's website at
http://www.globalmedtech.com/. About Global Med Technologies, Inc.
Global Med Technologies(R), Inc. is an international medical
software company which develops regulated and non-regulated
software products and services for the healthcare industry. As a
leading provider of blood and laboratory software applications and
services, Global Med's products are deployed in 20 countries and
serve over 1,600 transfusion centers, blood banks and laboratories.
Global Med's U.S. division, Wyndgate Technologies(R), provides
Vein-to-Vein(R) tracking through its Donor Doc(TM), SafeTrace(R),
SafeTrace Tx(R) and ElDorado Donor(TM) software products. Each
year, Wyndgate's products and services manage more than eight
million blood components, representing over 27% of the U.S. blood
supply. Global Med's European subsidiary, Inlog, SA, is a leading
provider of donor center and transfusion management systems as well
as cellular therapy software, laboratory information systems and
quality assurance medical software systems internationally. Inlog's
products include EdgeBlood*, EdgeTrack*, EdgeCell, EdgeLab and
SAPANET. Global Med's U.S. division, eDonor(R), provides a
web-based donor relationship management system that integrates
recruitment, scheduling, retention and fulfillment for national as
well as local community blood centers and hospitals. eDonor's
products and services are designed to complement Global Med's
strong line of international blood management and laboratory
information software and service solutions. Global Med's U.S.
subsidiary, PeopleMed(R), Inc., provides cost-effective customized
software validation, consulting and compliance solutions to
hospitals and donor centers. For more information about Global
Med's products and services, please call 800-996-3428 or visit
http://www.globalmedtech.com/, http://www.peoplemed.com/,
http://www.inlog.com/, http://www.edonor.com/, and
http://www.wyndgate.com/. *FDA 510(k) clearance required prior to
sales in the U.S. This news release may include statements that
constitute forward-looking statements, usually containing the words
"believe," "estimate," "project," "expects" or similar expressions.
These statements are made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ http:///DATASOURCE: Global Med
Technologies, Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med
Technologies, Inc., +1-303-238-2000, ; or investors, Paul Holm,
President of portfolio pr, +1-212-888-4570, , for Global Med
Technologies, Inc. Web Site: http://www.globalmedtech.com/
Copyright